Lundbeck
HLUN-B.CO
#2596
Rank
C$9.24 B
Marketcap
C$9.75
Share price
0.63%
Change (1 day)
13.94%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

EPS for Lundbeck (HLUN-B.CO)

EPS in 2025 (TTM): C$0.85

According to Lundbeck's latest financial reports the company's current EPS (TTM) is C$0.86. In 2024 the company made an earnings per share (EPS) of C$0.62 an increase over its 2023 EPS that were of C$0.48.

EPS history for Lundbeck from 2004 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C$0.8537.86%
2024C$0.6229.29%
2023C$0.4823.09%
2022C$0.3937.26%
2021C$0.28-84.61%
2020C$1.84-24.61%
2019C$2.44-42.06%
2018C$4.2040.7%
2017C$2.99146.26%
2016C$1.21-120.48%
2015C-$5.923231.32%
2014C-$0.18-115.78%
2013C$1.13-23.36%
2012C$1.47-48.01%
2011C$2.83-9.68%
2010C$3.1313.72%
2009C$2.7524.32%
2008C$2.22-6.05%
2007C$2.3681.77%
2006C$1.30-16.76%
2005C$1.56-17.58%
2004C$1.89